- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03590483
Outcomes in Spontaneous and ART Twin Pregnancies
Maternal and Perinatal Outcomes in Spontaneous Twins Versus Twins Conceived by Ovulation Induction and Assisted Reproductive Techniques: A Cross Section Study Within One Year
During the last decades, assisted reproductive technique has been transformed from a miracle to real and has become widely used for treatment human infertility.
this was associated with increased the rate of twin pregnancies
Study Overview
Status
Conditions
Detailed Description
Twin pregnancies are associated with an increased risk of maternal mortality & morbidity and an increase in the incidence of neonatal morbidity and mortality compared to singleton pregnancy.
The heterogeneous results reported so far can also depend on differences in the studied populations and/or in the management approach to twin pregnancy, variability in data regarding neonatal and maternal outcomes.
Evidence on pregnancy outcomes of twins conceived by artificial reproductive technology (ART) compared with those naturally conceived (NC) is conflicting, A 2004 systematic review and a large 2008 study both were praised that in cases of twin pregnancy after assisted conception the perinatal mortality is significantly lower, when compared with those spontaneously conceived .
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Kurdistan Region
-
Erbil, Kurdistan Region, Iraq, 44001
- Kurdistan Board for Medical speciality
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Twin delivery was identified when coming to outpatient clinic & labour ward into two groups, first group iatrogenic conceived twins (either ART, or medical ovulation induction mainly clomiphene citrate and gonadotrophins).The second group is a twin pregnancy who conceived naturally .
Demographic characters, maternal and neonatal outcomes were compared in both groups
Description
Inclusion Criteria:
- Twin delivered >24-week gestational age
- weight ≥ 500g
- Diachronic diamniotic twins.
Exclusion Criteria:
- Intrauterine fetal deaths
- Higher-order multiple pregnancies
- Deliveries complicated by early vanishing fetuses
- Twin pregnancies reduced to singleton
- Triple pregnancy reduced to twin.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Maternal diabetes using glucose tolerance test
Time Frame: up to 7 days postpartum
|
The diagnosis of GDM was based a fasting plasma glucose level of ≥5.6 mmol/L with 2 h plasma glucose level of ≥7.8 mmol/L
|
up to 7 days postpartum
|
|
Hypertension during pregnancy and preeclampsia diagnosed using ACOG guideline a) weight in kilogram b) Apgar score in first and 10th minutes c)Admission to neonatal intensive acre unit measured in days
Time Frame: up to 1 week postpartum
|
Systolic and diastolic blood pressure equal or more than140/90 mm Hg measured on two or more occasions after 20 weeks of gestation in previously normotensive women, with or without proteinuria (proteinuria of >100 mg/dL by urine analysis, or >300 mg/24 h)
|
up to 1 week postpartum
|
|
Maternal anemia using WHO criteria
Time Frame: up to 1 week
|
Hemoglobin level less than 11gm/dl
|
up to 1 week
|
|
Postpartum hemorrhage
Time Frame: up to 1 week
|
Bleeding from genital tract of 500 mL or more vaginally
|
up to 1 week
|
|
Neonatal weight in kilogram
Time Frame: up to 7 days
|
categorized as extreme low birth weight (LBW) for <1000 g, very LBW for 1000-1500 g, LBW for 1500-2500 g, and normal birth weight for >2500 g
|
up to 7 days
|
|
Neonatal Apgar(Appearance, Pulse, Grimace, Activity, and Respiration) score
Time Frame: first and fifth minute of life
|
Apgar scores includes 10 sores , 2 for each .
The Apgar score was classified as severely depressed <0-3>, moderately depressed<4-6> and excellent condition<7-10>
|
first and fifth minute of life
|
|
Admission to neonatal care unit in days
Time Frame: up to 7 days
|
Fetal care unit
|
up to 7 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Maternal mode of delivery
Time Frame: during labor
|
Cesarean section or vaginal delivery
|
during labor
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Diana Y. Rashid, Maternity Teaching Hospital
- Study Director: Shahla K. Alalaf, Hawler Medical University, College of Medicine
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SAlalaf
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.